METHODS, DEVICES, AND SYSTEMS FOR OBESITY TREATMENT
20170035593 ยท 2017-02-09
Assignee
Inventors
- Richard D.Y. Chen (Napa, CA, US)
- Craig A. Johanson (Napa, CA, US)
- Christopher S. Jones (Napa, CA, US)
- Reinhold H. Dauskardt (Napa, CA, US)
- Mark B. Taub (Napa, CA, US)
Cpc classification
A61B5/7282
HUMAN NECESSITIES
A61N1/372
HUMAN NECESSITIES
A61B5/686
HUMAN NECESSITIES
A61F2250/0003
HUMAN NECESSITIES
A61B5/746
HUMAN NECESSITIES
A61N1/08
HUMAN NECESSITIES
International classification
A61F5/00
HUMAN NECESSITIES
A61N1/08
HUMAN NECESSITIES
Abstract
Methods and systems for detecting wall breach in inflatable prostheses rely on intrusion of a body fluid or inflation medium to electrically alter a signaling circuit. In one embodiment, an open portion of a circuit is closed to enable or modify a transmitted signal In another embodiment, electrical current is generated to power an electrical transmission.
Claims
1. (canceled)
2. An obesity treatment system for deployment in a stomach of a patient, comprising: a plurality of adjacent, non-concentric, spaced apart inflatable space-filling compartments, wherein each compartment of the plurality of inflatable space-filling compartments has a respective inflated state volume during treatment of the patient; and at least two valves to introduce at least one fluid into the compartments of the plurality of inflatable space-filling compartments and to retain, after inflation, fluid in the plurality of inflatable space-filling compartments, wherein each valve is a one-way valve and wherein at least one of the at least two valves has a proximal end configured to removably attach to an inflation tube; wherein the plurality of inflatable space-filling compartments form, upon at least partially filling the plurality of inflatable space-filling compartments, a dual balloon system that floats within the stomach; wherein, upon inflation, the dual balloon system floats within the stomach without exerting pressure at any point in the stomach sufficient to cause ulceration.
3. The obesity treatment system of claim 2, wherein an outer surface of each of the inflatable space-filling compartments abuts a greater or lesser curvature of the stomach.
4. The obesity treatment system of claim 2, wherein the plurality of inflatable space-filling compartments are untethered in the stomach after inflation.
5. The obesity treatment system of claim 2, further comprising a flexible central spine structure spanning a gap between and connecting the plurality of adjacent, spaced apart inflatable space-filling compartments.
6. The obesity treatment system of claim 5, wherein the flexible central spine structure is in fluid communication with the valve system.
7. The obesity treatment system of claim 6, wherein the flexible central spine structure encloses an inflation lumen for introducing the fluid into the plurality of inflatable space-filling compartments.
8. The obesity treatment system of claim 2, wherein fluid in each of the plurality of inflatable space-filling compartments is a same type of gas.
9. The obesity treatment system of claim 2, further comprising chemicals adapted to be reacted to produce a gas that inflates at least one of the plurality of adjacent, spaced apart inflatable space-filling compartments.
10. A method for deploying a dual balloon system in a gastric cavity of a patient, comprising: introducing a least a first gastric balloon and a second gastric balloon to the gastric cavity, each of said balloons having a respective fill volume and a respective inflation lumen; at least partially filling each of the first gastric balloon and the second gastric balloon with the same type of fluid such that the first and second gastric balloons cooperatively form a dual balloon system that floats within the gastric cavity; wherein the first gastric balloon and a second gastric balloon are non-concentric and adjacent, wherein the inflation lumen of the first gastric balloon is separate from the inflation lumen of the second gastric balloon, wherein at least partially filling each of the first gastric balloon and a second gastric balloon comprises introducing fluid into the respective balloon via its respective inflation lumen.
11. The method of claim 10, wherein the dual balloon system, upon inflation, floats within the gastric cavity without exerting pressure at any point in the gastric cavity sufficient to cause ulceration.
12. The method of claim 11, wherein at least partly filling the first gastric balloon and second gastric balloon comprises: releasably attaching an inflation tube to at least one of the first and second gastric balloons; and introducing a fluid into the first gastric balloon and second gastric balloon.
13. The method of claim 12, wherein introducing a least the first gastric balloon and the second gastric balloon to the gastric cavity comprises introducing each gastric balloon through an esophagus of the patient.
14. The method of claim 13, wherein a diameter of each of the first and second gastric balloons is no larger than 2 centimeters prior to inflation.
15. The method of claim 10, wherein after inflation an outer surface of each of the first and second gastric balloons abuts against greater or lesser curvature of the gastric cavity.
16. The method of claim 10, wherein neither of the first and the second gastric balloon is tethered in the gastric cavity after inflation.
17. The method of claim 10, wherein a flexible central spine structure spans a gap between and connects the first gastric balloon and the second gastric balloon.
18. The method of claim 17, wherein the flexible central spine structure is in fluid communication with the valve system.
19. The method of claim 10, wherein at least partially filling each of the first gastric balloon and the second gastric balloon comprises reacting chemicals to produce a gas that inflates each of the first gastric balloon and the second gastric balloon.
20. A system for treating obesity, comprising: a first means for, upon inflation, occupying a first volume of a patient's stomach and floating in the patient's stomach; and a second means for, upon inflation, occupying a second volume of the patient's stomach adjacent to and abutting the first volume and floating in said patient's stomach; wherein the first means for occupying and floating includes a first means for receiving and retaining a gas such that the first means for occupying and floating occupies said first volume; wherein the second means for occupying and floating includes a second means for receiving and retaining a gas such that the second means for occupying and floating occupies said second volume adjacent to and abutting the first volume; wherein the first means for occupying and floating and the second means for occupying and floating are adapted to be removed after deflation through the esophagus of the patient.
21. The system of claim 20, wherein the first means for occupying and floating and the second means for occupying and floating are configured to float with without exerting pressure at any point in the stomach sufficient to cause ulceration.
22. The system of claim 21, wherein undue pressure against the stomach is avoided in part by a buoyancy provided by the gas.
23. The system of claim 20, further comprising a means for flexibly connecting the first means for occupying and floating and the second means for occupying and floating.
24. The system of claim 20, further comprising a means for producing an inflation gas through a chemical reaction.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
DETAILED DESCRIPTION OF THE INVENTION
[0040] Referring now to
[0041] Referring now to
[0042] As magnified in
[0043] After the balloon is deployed in the stomach, the external probe 130 is in contact with the surrounding tissue and body fluids and stomach contents. Upon a breach in the integrity of the wall, such as a tear in the outermost layer 102, the leakage of physiologic fluid or stomach contents with electrolytes into the tear forms a salt bridge that closes the circuit formed probes 130 and 112 and transponder 140. Once the circuit is closed, a toggle is switched in the transponder, which will be enabled to transmit a layer 102 breach signal. Tears through layer 106 in the balloon wall will allow leakage of physiologic fluid or stomach contents with electrolytes into the tear forming a salt bridge that closes the circuit formed probes 130 and 110 and transmitter 140. Closing this circuit switches another toggle in the transponder, which will be enabled to transmit a layer 106 breach signal.
[0044] The preferred radiofrequency identification circuit is shown schematically in
[0045] An exemplary reader module 120 is shown in
[0046] Referring now to
[0047] In the case of detecting a breach of the functional conductor, a lead 602 is shown with two electrically conductive probes 660 and 670 coupled to two ends of the functional conductor 650, as shown in
[0048] In the case where the functional conductor 650 is connected to another functional electrical conductor 680, as shown in
[0049] While the leads and connectors incorporating the detection system are illustrated independently above, they may be configured independent to each other in a device system or together in any combination using one or more common detecting or signaling circuits.
[0050] Referring now to
[0051] While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.